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Diabetes care costs amount to 8% of all national healthcare expenditure referred 
to hospitalization (50.1%), outpatient services (17.4%), other drugs (21.3%), drugs for 
diabetes (6.9%) and medical devices (4.3%) (De Berardis, et al., 2012). 
Insulin therapy is a pharmaceutical treatment option used to lower blood glucose in all 
patients with type 1 diabetes (T1D) and in a part of patients with type 2 diabetes (T2D).  
For insulin-treated patients blood glucose optimisation can be managed by different 
types of insulin that can be integrated in various medical devices technologies such as 
insulin pumps (Continuous Subcutaneous Insulin Infusion, CSII) and insulin pens 
(Multiple Daily Insulin Injection, MDI).  
Aim 
To draw the profile of patients in insulin therapy with insulin pumps and with multiple 
daily injections by identifying the variables that influence the use and the choice of two 
different medical devices.  
Tools and Methods 
We developed the PLDI questionnaire to rate clinical and physical characteristics of 
these patients, their way of life, their lifestyles in general. The Explorative Factor 
Analysis (EFA) was performed to define the profiles of insulin-treated patients with 
diabetes enrolled in our study and the Confirmatory Factor Analysis (CFA) was 
performed to validate the relationships between the factors that identify the profiles that 
are defined with the EFA. Regression Models were performed to estimate the effects of 
demographic variables, clinical data, lifestyles and behaviour on the choice of medical 
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Results 
The whole PLDI questionnaire has a good internal items consistency (α=.85. 
Thanks to EFA three factors were lastly extracted: “General Characteristics”, 
“Employment Information” and “Eating Habits” that were finally accepted and 
confirmed by CFA. General Characteristics and Eating Habits also resulted the 
independent variables highlighted  in the regression models’ results. 
Conclusions 
The results provide supporting evidence that there are many, but not only clinical, 
characteristics of patients with diabetes useful to the appropriate choice of medical 
device for insulin treatment. 
This study is not devoid of limitations and the main is based on the sample and its 
composition, which limits the generalizability of results. Therefore, next development is 
to make the results more generalizable in order that they can be used by policy makers 
in healthcare for a better management of resources and the best appropriateness of 
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Diabetes is a chronic disease that occurs either when the pancreas does not 
produce enough insulin or when the body cannot effectively use the insulin it produces. 
Insulin is a hormone that regulates blood sugar.  During 2016, there are over 3 million 
200 thousand people in Italy who claim to be suffering from diabetes, the 5.3% of the 
entire population (16.5% among the people of 65 years and beyond) (ISTAT, 2017). 
Diabetes care costs amount to 8% of all national healthcare expenditure referred to 
hospitalization (50.1%), outpatient services (17.4%), other drugs (21.3%), drugs for 
diabetes (6.9%) and medical devices (4.3%) (De Berardis, et al., 2012). 
Insulin therapy is a pharmaceutical treatment option used to lower blood glucose 
in all patients with type 1 diabetes (T1D) and in a part of patients with type 2 diabetes 
(T2D) whose pancreas don’t produce enough amounts of the hormone insulin.  
For insulin-treated patients blood glucose optimisation can be managed by 
different types of insulin that can be integrated in various medical device technologies 
such as insulin pumps (Continuous Subcutaneous Insulin Infusion, CSII) and insulin 
pens (Multiple Daily Insulin Injection, MDI). Both CSII and MDI are forms of 
intensified insulin treatment, but CSII mimics a physiological situation better (Jeitler, et 
al., 2008). 
 CSII technology was introduced in the 1970s to achieve normoglycaemia in people with 
type 1 diabetes mellitus (Pickup, et al., 1978). The first insulin pump had to be worn 
like a backpack, whereas nowadays a traditional CSII device includes: the pump and its 
controls, the processing module, the batteries, a disposable reservoir for insulin, a 
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tubing system to interface the insulin reservoir to the cannula. The pump delivers 
insulin in two ways:  
 a basal dose which is infused continuously to correct the basal rate; 
 the bolus doses which are infused “on-demand” to cover food eaten or to correct a 
high blood glucose level. 
The main difference between CSII than MDI treatment is obviously the basal dose, that  
is not provided in MDI. 
According to the third Italian survey, the number of patients with T1D and T2D 
that use CSII increased by 396% between 2005-2013 (Bruttomesso, et al., 2015). These 
values might keep increasing, and more work is needed to ensure uniform treatment 
strategies throughout the country. In fact, the spread of CSII resulted really uneven 
between Italian regions and even between different diabetes care centres of the same 
region. 
 
1.1 Related literature 
  
CSII is recommended as a possible treatment for patients who attempt to achieve 
target haemoglobin levels following high levels of HbA1c (8.5% or above) with MDI 
despite carefully managing their diabetes (NICE, 2008). 
Candidates for CSII include patients with type 1 diabetes and patients with type 2 
diabetes who are insulin dependent and have inadequate control with MDI.  
CSII should only be used in patients who are motivated, knowledgeable in diabetes self-
care, take insulin multiple times per day, assess blood glucose levels multiple times 
daily, are motivated to achieve tighter glycaemia control, are willing, intellectually and 
physically able to undergo the rigors of insulin pump therapy initiation and maintenance 
(AACE/ACE Diabetes Guidelines, 2015). The American Diabetes Association (ADA) 
annually publishes its standards of medical care for patients with diabetes: for 
glycaemia treatment it is recommended that individuals who have been successfully 
using CSII should have continued access after they turn 65 years old (American 
Diabetes Association, 2016). 
Italian standards recommend the advice of expert panels who have the task of 
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poor glycaemia control and/or recurrent hypoglycaemia despite an optimal basal-bolus 
regimen (level III strength, strength of recommendation B) (AMD-SID, 2014). 
Furthermore, there is a lot of considerable research and tools designed to assess 
patient satisfaction, diabetes knowledge and diabetes QoL (Burroughs, et al., 2004; 





Giulia Abis, Diabetes and Medical Devices: which Device for which Patient 




The aim of this study is to draw the profile of patients in insulin therapy with 
insulin pump (CSII) and with multiple daily injections (MDI) by identifying the 
variables that influence the use and the choice of two different medical devices. We rate 
clinical and physical characteristics of these patients, their way of life, the work they do 
and its organization, their qualifications, physical activity and other recreational 
interests practiced, their marital status, the parity of pregnancies and the number of 
children (only for women), their lifestyles, eating and behavioural habits. 
 
2.1 Research planning 
A cross-sectional study was planned and has involved people in insulin treatment using 
MDI and CSII for at least six months, residents in Sardinia during the period of study 
(since 2015) and being treated at diabetes centres in the same region. 
The patients enrolled in the study are adult patient (≥18 years old). The date of birth will 
be considered to calculate the age (years) of the enrolled patients. 
The informed consents for the participants at the study are reported in Appendix 
A in Italian language.  
Data collection includes patients’ clinical data and non-clinical data gathered by the 
structured questionnaire with a majority of closed questions. 
The form of clinical data available only in Italian language is reported in Appendix B.  
A structured interview is used as a method of data collection proposed to each patient 
enrolled in the study. The interview is conducted by the same person. Although the 
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take direct vision of the questionnaire; in this way the emotional independence of the 
answers to the questionnaire and the consequent absence of conditioning by previously 
reading of the whole text is ensured. 
The final research is preceded by a pilot study designed, to reveal deficiency in 
the proposed structured questionnaire (to check the comprehensibility of the questions 
and the logical structure of the same, as well as to monitor the time of detection 
information) and to validate it.   
A pilot study is understood as a pre-testing or ‘trying out’ for further 
epidemiological studies (Baker, 1994). It should be recognized that the pilot studies 
may have a number of limitations and as a chance to make inaccurate forecasts or 
assumptions related to the sample size. Although pilot study findings may offer some 
indication of the likely size of the response rate in the main survey, they cannot 
guarantee this because they don’t have a statistical foundation and are nearly always 
based on small numbers (Van Teijlingen & Hundley, 2001).  
 
 
2.2 Ethical Approval 
 
Before conducting the study, we requested the ethical approval from the Local 
Health Authority of Sassari’ Ethic Committee, Sardinia Region (Italy). We have 
obtained the ethical approval to conduct this research and to use documents reported in 




                                                 
1
 In Appendix C is reported the 2
nd
 version of the questionnaire, after piloting test.  
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Tools and Methods 
 
 
3.1 Patients’ Lifestyle with Diabetes Insulin-treated (PLDI) 
Questionnaire 
Currently, for my knowledge, there are no recommended standards which enable 
to correlate patients’ lifestyle with insulin therapy and technology used. Because no 
tools are available to assess the choice of medical device for insulin treatment based on 
patients’ lifestyle, we developed a questionnaire to study the way of life of patients with 
diabetes in insulin-treatment. We call this tool Patients’ Lifestyle with Diabetes Insulin-
treated (PLDI) questionnaire. 
The PLDI questionnaire was validated after the pilot study (see Appendix C) in 
Italian language and contains questions about perception of health, satisfaction of 
medical device and patient’s lifestyle. To make sure that the items of PLDI 
questionnaire were understandable, an expert panel of healthcare professionals reviewed 
the tool and all items. 
Moreover, the PLDI questionnaire contains questions about medical device for 
insulin treatment used, the length of their use and general information of the patients 
with type 1 and type 2 diabetes. There are also demographic items providing 
information about professional activity, marital status, qualification, length of time since 
diagnosis of diabetes and for women also the number of pregnancies. There are in total 
25 items. 
Tools and Methods 14
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For questions on the perception of health and some on the patient’s lifestyle 
(eating habits, sport, qualification, etc.) the ISTAT survey questionnaire multipurpose 
was considered (Istat, 2015).  
The PLDI questionnaire is the same for patients with type 1 and type 2 diabetes. 
Every item is measured using Likert scale scores expressed in 5 dimensions from 1 to 5 
with the assumption of ordinals from low risk to high risk. 
 
3.1.1 Pilot testing 
For the pilot test of the PLDI questionnaire, all detailed information of the study 
was provided to prospective participants and written consents were obtained. People 
with type 1 and type 2 diabetes were recruited from a Primary Health Care Centre of 
Sardinia (Italy) (see 4.2.1). 
Health professionals of diabetes were asked to introduce the pilot study to patients 
with type 1 and type 2 diabetes and to request them if they would take part in the 
survey. The PLDI questionnaire was submitted under interview form to patients 
interested to participate and who had signed the informed consent. The PLDI 
questionnaire was performed, for each insulin-treated patient, by the same interviewer.  
The interaction between interviewer and interviewee was face-to-face and patients 
enrolled in the study didn’t take direct vision of the questionnaire; in this way the 
emotional independence of the answers was ensured to the questionnaire and the 
consequent absence of conditioning by previously reading it too.  
The internal consistency of the items of the PLDI questionnaire was assessed by 
Cronbach’s Alpha (α) index (Armitage & Colton, 1998) using STATA 14. The α value 
was calculated for the whole questionnaire. We performed also a descriptive analysis by 
medical device used, gender, age, qualification and marital status. 
 
3.2 Statistical Analysis 
 
The Explorative Factor Analysis (EFA) was performed to define the profiles of 
insulin-treated patients with diabetes enrolled in our study and the Confirmatory Factor 
Analysis (CFA) was performed to validate the relationships between the factors that 
identify the profiles that are defined with the EFA.  
Tools and Methods 15
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The Regression Models were performed to estimate the effects of demographic 
variables, clinical data, lifestyles and behaviour on costs related to medical devices.  
The EFA and the Regression Models were implemented in SPSS 24, while the CFA was 
ran with AMOS 24. 
Univariate analyses preceded multivariate analyses. For the univariate analyses, 
descriptive statistics (mean, standard deviation, minimum and maximum values, 
frequencies) are calculated for quantitative and qualitative variables, respectively.  
3.2.1 Exploratory Factor Analysis 
Exploratory Factor Analysis (EFA) is a type of factor analysis, and the purpose is 
to identify the underlying dimensional structure of a set of measures summarizing data 
so that relationships and patterns can be easily interpreted and understood. So that, EFA 
tries to uncover complex patterns by exploring the dataset and testing predictions (Yong 
& Pearce, 2013). Factor analysis is useful for studies that involve a few or hundreds of 
variables, items from questionnaires, or a battery of tests (Rummel, 1970). 
In EFA, measurable and observable variables can be reduced to fewer “latent 
variables” that share a common variance, are unobservable and non directly measured 
but are used to represent variables (Bartholomew, 1980). These variables are 
interdependent: there are no dependent or independent variables, but they are correlated. 
For each factor or latent variable we define: 
- factor loading, a measure of how much a observed variable contributes to the 
factor (the larger the factor loading the more the variable has contributed to 
that factor); 
- factor score, the weights of each observed variable in producing a score 
representing each factor; 
- eigenvalue, the sum of the squared factor loadings for a given factor; 
- communality, the variance in the observed variables which are accounted for by 
a common factor (shows how much each variable can be predicted the 
extracted factors). 
The variance is equal to the square of the factor loadings (Child, 2006). 
Tools and Methods 16
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In the mathematical model, p denotes the number of variables (X1, X2,…, Xp) and 
m defines the number of underlying factors (F1, F2,…,Fm). Xj is the variable represented 
in latent factors. Thus, this model assumes that there are m underlying factors whereby 
each observed variables is a linear function of these factors together with a residual 
variant.  
                            
 
The factor loadings are aj1, aj2,…, ajm which denotes that aj1 is the factor loading of j
th
 
variable on the 1
st
 factor. The specific or unique factor is denoted by ej. 
The communality is denoted by h
2 
and is the summation of the squared factor ladings: 
 
  
     
     
        
  
 
The unique variance is denoted by u
2
 and is the proportion of the variance that excludes 
the common factor variance which is represented by the formula: 
 
  
      
  
 
Thus,   
  is the variance due by variable j. 
If you know that unique variance is split into specific variance and error variance, the 
formula of the total variance is: 
 
                                
 
Factor loadings are very similar to weights in multiple regression analysis, and they 
represent the strength of the correlation between the variable and the factor. Factor 
analysis uses matrix algebra when computing its calculations. The basic statistic used in 
factor analysis is the correlation coefficient which determines the relationship between 
two variables. Generally, a factor analysis performed using a correlation matrix 
produces standardized data, thus it is recommended for variables that are not 
meaningfully comparable (e.g., items from different scales). On the other hand, factor 
analysis performed using a covariance matrix is conducted on variables that are similar 
(e.g., items from the same scales). The basic idea behind this model is that factor 
Tools and Methods 17
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analysis tries to look for no correlations between any pairs of Xi and Xj because the 
factors themselves will account for the correlations. This means that all pairs of any two 
observed variables (Xi, Xj,…, Xp), are conditionally independent given the value of F1, 
F2,…, Fm (Yong & Pearce, 2013). 
 
The process of conducting an EFA involves three steps: 
1. extraction and rotation; 
2. evaluation goodness of the model; 
3. interpretation of results. 
1. Extraction refers to the process of determining how many factors best explain the 
observed covariation matrix within the data set. The best is the fewest number of factors 
that explains the largest amount of variation of the observed variables. There are many 
methods for conducting an exploratory factor analysis: principal components (PC) 
unweighted least squares (ULS), generalized least squares (GLS), maximum likelihood 
(ML), principal axes factoring (PAX), alpha factoring (AF) and image factoring (IF). 
Information on relative strengths and weaknesses of these techniques is scarce, often 
only available in obscure references. It is often hard to figure out which method a 
textbook or journal article author is describing, and whether or not it is actually 
available in the software package the researcher is using (Costello, 2005). 
If data is relatively normally distributed, maximum likelihood is the best choice; if the 
assumption of multivariate normality is severely violated one of principal factoring 
methods is recommended (Costello, 2005). 
Two methods to determine the appropriate number of factors to extract are the Kaiser’s 
Criterion and the Scree Test. The Kaiser’s Criterion suggests retaining all factors that 
are above the eigenvalue of 1 (Kaiser, 1960). In fact, because we are interested in 
explaining as much variance in observed indicators as possible, we can decide to retain 
only those latent variables with sufficiently high eigenvalues. Scree Test is based on 
scree plot and considers the number of factors above the point of inflexion, but is often 
hard to interpret and is subjective and open to different interpretations. 
Factors are rotated for better interpretation. The goal of rotation is to attain an 
optimal simple structure which attempts to have each variable load on as few factors as 
possible, but maximizes the number of high loadings on each variable (Rummel, 1970). 
There are orthogonal and oblique rotation. Orthogonal rotation is when the factors are 
Tools and Methods 18
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rotated 90° from each other and it is assumed that the factors are uncorrelated, oblique 
rotation is when the factors are not rotated 90° from each other and it is assumed that 
the factors are correlated (Rummel, 1970). Two common orthogonal techniques are 
Quartimax and Varimax rotation: Quartimax involves the minimization of the number 
of factors needed to explain each variable, while Varimax minimizes the number of 
variables that have high loadings on each factor and works to make small loadings even 
smaller. The common oblique rotation techniques are Direct Oblimin and Promax. 
Direct Oblimin attempts to simplify the structure and the mathematics of the output, 
while Promax involves raising the loadings to a power of four which ultimately results 
in greater correlations among the factors and achieves a simple structure (Yong & 
Pearce, 2013). Conventional wisdom advises researchers to use orthogonal rotation 
because it produces interpretable results more easily (Costello, 2005).   
So, if we decide that our factors should be correlated then we select an oblique solution, 
whereas if you decide that our factors should not be correlated then we select an 
orthogonal solution. 
2. Among evaluation goodness of the model we consider Kaiser-Meyer-Olkin (KMO) test, 
Bartlett’s tests and Goodness-of-fit Test. KMO test is a measure of how suited your data 
is for factor analysis. The test measures sampling adequacy for each variable in the 
model and for the complete model. The statistic is a measure of the proportion of 
variance among variables that might be common variance. KMO returns values between 
0 and 1. A rule of thumb for interpreting the statistic: 
 KMO values less than 0.6 indicate the sampling is not adequate and that 
remedial action should be taken; 
 KMO values between 0.6 and 0.69 are mediocre; 
 KMO values between 0.7 and 0.79 are middling;  
 KMO values between 0.8 and 1 indicate the sampling is adequate. 
Bartlett’s test shows the homogeneity of variance: the null hypothesis is all the 
population variances (k populations being compared) are equal or the correlation matrix 
is an identity matrix. The alternative hypothesis is the population variances are not all 
equal. This means at least one is not equal to the others. The test does not explicitly 
determine which one is different, just that at least one is different. 
The Goodness-of-fit Test determines if the sample data (correlations) is likely to arise 
from the correlated factors. In this situation we want the probability value of the Chi-
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Square statistic to be greater than the chosen alpha (generally .05), or that is accepted 
the null hypothesis that the model fits the data.  
3. The interpretation is naming the factors using our psychological knowledge to provide a 
meaningful understanding of the common feature among the relevant items.   
Among requirements, to be labelled as a factor it should have at least 3 variables; a 
factor with 2 variables is only considered reliable when the variables are highly 
correlated with each other (r > .70) but fairly uncorrelated with other variables (Yong & 
Pearce, 2013). Generally, the correlation r must be .30 or greater to suggest a very weak 
relationship between the variables (Tabachnick & Fidell, 2007).  
As a rule of thumb, a bare minimum of 10 observations per variable is necessary to 
avoid computational difficulties. Also, the theory states that the number of variables 
used in a study should be much greater than the number of extracted factors. Generally, 
it is considered a good over determination condition of factors when the proportion 
between observed used variables and extracted factors is 4-5 to 1 (Pannocchia & 
Giannini, 2007). 
EFA can provide an infinitive number of possible solutions and the method of 
determining the appropriate number of factors to retain is very subjective. EFA is also a 
highly data-driven rather than a theory-driven method of investigation. 
3.2.2 Confirmatory Factor Analysis 
Confirmatory Factor Analysis (CFA) is a type of factor analysis, and the purpose 
is to test whether a dimensional structure is consistent with the structure obtained in a 
particular set of measures. In CFA, the researchers look for what they expect to find 
before doing the analysis and then seek to confirm this using the appropriate techniques 
(Stewart, 2001).  
During CFA, the researchers use a hypothesized model that can be the result of a 
previously conducted analysis (i.e. EFA) or a priori built-in model based on knowledge 
of the studied phenomenon and the related literature. Both cases, CFA attempts to 
confirm hypotheses and represent variables and factors using path diagram. Often CFA 
results and their measurement model are used for testing a Structural Equation Model 
(SEM).  
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It is common to display confirmatory factor models as path diagrams. CFA uses 
distinct categories of variables that are termed in different ways. Observed variables are 
also named measured, indicator and manifest. Researchers and software traditionally 
use a square or rectangle to designate them graphically. Unobserved variables are also 
named latent factors, factors or constructs. Researchers and software traditionally use 
circles or ovals to designate them graphically. Figure 1 shows a generic path diagram 
where the unobserved or latent variables are represented as circles at the top and the 
observed variables are represented as rectangles in the middle.  
The circles at the bottom are the unique factors or measurement errors in the variables. 
The unique factors differ from factors because their effect is associated with one only 
observed variables. Each unique factor effects only a single variable and incorporates 
the variance in each observable variable not captured by the latent factors, such as 
measurement error. The straight lines pointing from each factor to the observed 
variables indicates the causal effect of each latent variable on the observed variables: in 
factor analysis the researchers almost always assume that the latent variables “cause” 
the observed variables. The scores of the relationship between factors and observed 
variables are the factor loadings (see 3.2.1). The two-headed curved arrow between 




CFA is theory-driven and it’s possible to place substantively meaningful 
constraints on the factor model, such as setting the effect of one latent variable to equal 
   Figure 1. Generic path diagram of CFA 
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zero on a subset of the observed variables. The advantage of CFA is that it allows to test 
hypotheses about a particular factor structure (Albright, 2006-2008). 
The graphic representation is the hypothesized model that is to be tested to see 
how well it fits the observed data.  
The confirmatory factor model can be summarized by the equation 
 
       
 
in which   is the vector of observed variables,   is the matrix of loadings connecting 
each    to the   ,   is the vector of factors and   is the vector of unique factors. It is 
assumed that the unique factors have a mean of zero (E( )=0), and that the factors and 
unique factors are uncorrelated (E(   )=0). The equations of the model for Figure 1 can 
be written as: 
 
First Factor Second Factor 
            
            
            
            
            
            
 
The equations of the model are similar to regression analysis, but the primary difference 
between these factor equations and regression analysis is that    are unobserved. The 
sample covariance matrix   for   can be decomposed as follows (when the   variables 
are measured as deviations from their means): 
 
         
 
where   is the covariance matrix of the   factors and   is the covariance matrix of the 
unique factors   (Bollen, 1989). Several different fitting functions exist to determine the 
closeness of the implied covariance matrix to the sample covariance matrix and 
maximum likelihood is among the most common. 
 
The first step in CFA is determining whether the specified model is identified. In 
fact, if the model is unidentified it means that it is impossible to come up with unique 
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parameter estimates. That is when the factors model can make true for infinite number 
of values. In CFA, a model is identified if all of the unknown parameters can be 
rewritten in terms of the variances and covariances of the   variables (Bollen, 1989). 
Without introducing some constraints any confirmatory factor model is not identified 
because the latent variables are unobserved and hence their scales are unknown. It 
therefore becomes necessary to set the metric of the latent variables in some manner; the 
two most common constraints are to set either the variance of the latent variables or one 
of their factor loadings to one. 
The second step is to assess how well the model matches the observed data. About 
simple size, it is important because it relates to the stability of the parameter estimates, 
but there is no exact rule for the number of participants (Shreiber, et al., 2006). About 
handling of missing data, in general, pairwise deletion is not recommended and listwise 
deletion is problematic unless the missing data has proved to be missing at random 
(Shreiber, et al., 2006). The core of the second step, apart from representing the impact 
of one latent construct on another or the latent construct on the observable variables, is 
the examination of the coefficients of hypothesized relationships of whether the 
hypothesized model is a good fit to the observed variables (Shreiber, et al., 2006).  
The model adequacy is measured with the conventional overall test of fit, χ2 statistic, 
where the null hypothesis under test is that the model fits the data.         
In reference to model fit, there are used numerous goodness-of-fit indicators to assess a 
model. Fit indexes can be classified into absolute and incremental fit indexes (Hu & 
Bentler, 1999) also known tests of relative fit. The absolute fit indexes assess how well 
a priori model reproduces the sample data. Examples of absolute fit indexes include the 
Goodness-of-Fit Index (GFI), the Adjusted Goodness-of-Fit Index (AGFI), the Root 
Mean Squared Residual (RMR) and the Root Mean Square Error of Approximation 
(RMSEA).  
The incremental fit indexes measure the proportionate improvement in fit by comparing 
a target model with a more restricted, nested baseline model. Examples of incremental 
fit indexes are the Normal Fit Index (NFI), the Tucker-Lewis Index (TLI) and the 
Bentler’s Comparative Fit Index (CFI). 
Fit indexes were designed to avoid some of the problems of sample size and 
distributional misspecification associated with the conventional overall test of fit (the χ2 
statistic) in the evaluation of the model. However, this promising claim that fit indexes 
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would more unambiguously point to model adequacy as compared to the χ2 test has 
little empirical support (Hu & Bentler, 1999).  
The pressing issue is the selection of the “rules of thumb” conventional cutoff 
criteria for given fit indexes used to evaluate model fit; researchers often question the 
adequacy of these conventional cutoff criteria due to lack of empirical evidence and 
compelling rationale for these rules of thumb. Many studies evaluated conventional 
cutoff criteria for fit indexes, but finally they should be considered only as rules of 
thumb. Table 1 reports a chart with the conventional cutoff criteria related fit indexes of 
the model (Shreiber, et al., 2006; Hu & Bentler, 1999). About conventional overall test 
of fit χ2 statistic in the evaluation of the model, so that the null hypothesis can be 
accepted, we hope to find a small, non-significant χ2 value for this test. So, failure to 
reject the null hypotheses is therefore a sign of a good model fit. 
 
Fit Statistic Recommended Value 









                    Table 1. Fit statistics of the measurement model 
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3.2.3 Regression Analysis 
Regression analysis is a set of techniques for estimating relationships between 
variables. It can be discriminated between simple linear regression and multiple linear 
regression. The equation for the simple linear regression model is listed below, where   
is called the independent variable or predictor variable and   is called the dependent 
variable or response variable. 
 
         
 
Regarding quantities from the fit,    is the intercept of the line and    is the slope of the 
line that corresponds at regression coefficient. A value of the slope very close to zero 
indicates little to no relationship, large positive or negative values indicate large positive 
or negative relationships, respectively.  
In multiple linear regression there are more variables. In this case instead of just a 
single scalar value  , there is a vector           for every data point  .  
The linear equation model for multiple linear regression model is: 
 
                         
 
Typically, we will use an analysis of variance (ANOVA) test to measure this. If the 
ANOVA test determines that the model explains a significant portion of the variability 
in the data, then we can consider testing each of the hypotheses and correcting for 
multiple comparisons.  
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4.1 Pilot Study: PLDI questionnaire validation  
Thirty-three patients with diabetes of type 1 and 2 were randomly selected from 
the database of a Primary Health Care Centre of Sardinia (Italy). After validation, only 
32 questionnaires were considered for statistical analysis because during PLDI 
questionnaire validation one item was modified. Therefore, 97% of demographic 
information of the 33 patients interviewed were considered.  
A value of α=.85, calculated for the whole questionnaire, indicates a good internal 
items consistency.  
Slightly more than half the respondents are female (55%), 7 (22%) use CSII and 
25 (78%) use MDI (see Table 2).  
Age of 32 respondents range from 21 to 70 years old with a mean of 52 years. 
Qualification ranges from a completed doctoral or university degree to no qualifications, 
with 50% having completed just a secondary school degree.  
In examining respondents’ marital status, 16 (50%) are married and live with their 
spouse.  
Examining respondents’ insulin treatment, the use of MD ranged from 6 months to 20 
years and 87.5% are more than satisfied.  
The mean of time of the interviews is 13.10 minutes (CI95%: 11.90-14.29). 
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           |             MD           | 
    Gender |      CSII        MDI     |     Total 
-----------+------------------------------------------- 
    Female |         4         13     |        17  
        %r |     23.53      76.47     |    100.00  
        %c |     57.14      52.00     |     54.84  
-----------+------------------------------------------- 
      Male |         3         12     |        15  
        %r |     21.43      78.57     |    100.00  
        %c |     42.86      48.00     |     45.16  
-----------+------------------------------------------- 
     Total |         7         25     |        32  
        %r |     21.88      78.12     |    100.00  
        %c |    100.00     100.00     |    100.00 
 
      Table 2. Descriptive results by Gender and Medical Device (MD) 
4.2 Final Study 
4.2.1 The Sample 
We used the database of Diabetes Centre of ASSL of Oristano as a sampling 
frame to obtain access to the population of interest. This population is composed by 
patients with diabetes in insulin therapy. 
During the 2016, adult patients (age ≥18 years old) with diabetes in insulin treatment 
were 2402, of which 180 were using CSII technology. 
We random selected a sample of 134 patients with diabetes in insulin therapy 
from this database. Of these insulin-treated patients, 19 use CSII technology and 115 
use MDI one.  
If we consider a subgroup of patients in insulin treatment born afterwards 
01.01.1946, the number of patients from the database of Diabetes Centre of ASSL of 
Oristano is 1056, of which 160 patients use CSII technology. Calculating that the 
percentage of patients enrolled in the study is 12.7% of the total patients with diabetes 
and in insulin treatment, then 11.9% of which use CSII and 12.8% of which use MDI. 
Six patients of the 134 interviewed were excluded from the study for different 
reasons: 
 1 was under the age of 18 years old; 
 1 had already been excluded during the validation of the PLDI questionnaire (see 
4.1); 
Results  27 
 
 
Giulia Abis, Diabetes and Medical Devices: which Device for which Patient 
Tesi di Dottorato in Scienze Biomediche – Curriculum Sanità Pubblica, Università degli Studi di Sassari 
 
 2 were excluded because their diabetes were not categorized as type 1 or type 2, but 
as other;  
 4 were excluded because they had been using the device for less than 6 months (see 
2.1). 
4.2.2 Descriptive Analysis 
The sample was analysed by gender, age, type of diabetes, years by diagnoses of 
disease, type and years of using medical devices (MDI or CSII). The sample is made 
from 126 patients, 46% females (see Table 3) with the mean age of 54 ± 3 (years) and 
54% males with the mean age of 50 ± 3 (years). The mean age of the whole sample is 
52 ± 2 (years). 
 
         
    Gender |      Freq.   Percent     |        
-----------+--------------------------| 
    Female |        58      46.03     |       
      Male |        68      53.97     |     
-----------+--------------------------| 
     Total |       126     100.00     | 
-----------+--------------------------| 
 Table 3. Distribution of the sample by Gender 
 
Regarding the type of diabetes (1 or 2), 54% of the sample is represented by 
patients with T1D diabetes, of which mean year of diagnosis of disease is 22 ± 13 
(years) and 46% of the sample is represented by patients with T2D diabetes, of which 
mean year of diagnosis of disease is 13 ± 8 (years). The mean year of diagnosis of 
disease in all patients is 18 ± 12 (years); for males is 19 ± 11 (years) while in females is 
17 ± 13 (years). 
About medical devices, 110 (87.3%) patients use MDI technology of which 
57.3% are male; 16 (13.7%) use insulin pump (CSII) of which 68.8% are female (see 
Table 4). Those who use MDI discovered their disease 18 ± 12 years ago (min 1, max 
47), whereas who use CSII discovered the disease 21 ± 12 years ago (min 4, max 44). 
The association between gender and medical device used although not statistically 
significant highlights a relationship (χ2=3.81, p=.051).  
 
 
Results  28 
 
 
Giulia Abis, Diabetes and Medical Devices: which Device for which Patient 
Tesi di Dottorato in Scienze Biomediche – Curriculum Sanità Pubblica, Università degli Studi di Sassari 
 
 
           |          MD          | 
    Gender |       MDI       CSII |     Total 
-----------+----------------------+---------- 
    Female |        47         11 |        58  
      %c   |     42.73      68.75 |     46.03  
-----------+----------------------+---------- 
      Male |        63          5 |        68  
      %c   |     57.27      31.25 |     53.97  
-----------+----------------------+---------- 
     Total |       110         16 |       126  
      %c   |    100.00     100.00 |    100.00  
 
Pearson chi2(1) =   3.8076   Pr = 0.051 
Table 4. Relationship between gender and Medical Devices (MD) 
 
Of the sixteen patients that use CSII technology, 94% are affected by T1D diabetes (ten 
females and five males), while only 6% are patients with T2D diabetes (a female) (see 
Table 5). This is in according to international guidelines that recommend the use of 
CSII in people with T1D diabetes (ADA, 2014; NICE, 2010).     
 
 
   Type of |            MD        | 
  Diabetes |       MDI       CSII |     Total 
-----------+----------------------+---------- 
       1   |        53         15 |        68  
      %c   |     48.18      93.75 |     53.97  
-----------+----------------------+---------- 
       2   |        57          1 |        58  
      %c   |     51.82       6.25 |     46.03  
-----------+----------------------+---------- 
     Total |       110         16 |       126  
      %c   |    100.00     100.00 |    100.00  
 
     Fisher's exact =  0.001 
Table 5. Relationship between type of diabetes and Medical Devices (MD) 
 
The sixty-three men that use MDI have a mean age of 51 ± 13 (years) with a minimum 
age of 24 and a maximum age of 66. These men have been using MDI technology for a 
mean of 109 ± 81 months with a minimum value of 6 and a maximum of 360 months. 
The five men that use CSII have a mean age of 41 ± 23 (years) with a min of 21 and a 
max of 66. These men have been using CSII technology for a mean of 53 ± 46 months 
with a minimum of 12 and a maximum of 108 months. 
The forty-seven women that use MDI have a mean age of 56 ± 11 (years) with a 
minimum age of 23 and a maximum age of 70. These women have been using MDI 
technology for a mean of 88 ± 85 months with a minimum of 6 and a maximum of 312 
months. The eleven women that use CSII have a mean age of 48 ± 13 (years) with a 
minimum age of 27 and a maximum age of 64. These women have been using CSII 
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technology for a mean of 70 ± 44 months with a minimum of 12 and a maximum of 144 
months. 
The Skewness/Kurtosis test was performed to determine the normality of age by 
MD groups. The hypothesis of normality for age is rejected (p=0.0021) so, the  Mann-
Whitney U test was applied to compare age’s medians in each group and the result 
shows a not significant value (p=0.126). 
The difference of proportions by MD groups was tested by Z test and the result 
showed a high significant z value (z=6.71, p<0.001).  
As regards the PLDI questionnaire’s replies we calculated the frequency for each 
question and evaluated the relationships between them and the type of diabetes, medical 
devices and gender. We reported in Tables 6-8 the modal value of each item by each 
medical devices group and for the whole sample. The corresponding frequencies are 
reported in brackets.  
Regarding perception of health we had asked to patients how their health was, if 
they check their weight and how often (questions 1-2 respectively). 
 
Questions about perception of health 
Item CSII MDI Whole Sample 




Check their weight at 




Check their weight at 




Check their weight at least 
once per month (32.5%) 
 
Check their weight at least 
once per year (32.5%) 
 
Table 6. Modal values and corresponding frequencies of items for Perception of Health in patients by medical 
devices groups 
Regarding questions about satisfaction of medical device, we had asked patients 
which was the reason why they used this device, how satisfied they were to use it and 
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Questions about satisfaction of Medical Device 
Item CSII MDI Whole Sample 
III 
 
Use the device advised by 
the doctor (75%) 
 
 
Use the device advised by 
the doctor (90%) 
 
 
Use the device advised by 


























Does not influence (76%) 
 
Table 7. Modal values and corresponding frequencies of items for Satisfaction of Medical Device in patients by 
medical devices groups 
Regarding questions about patient’s lifestyle we had asked patients what their 
main meal was, if they had breakfast and what they ate, where they had lunch, how 
often they ate different kinds of foods, how often they drank different kinds of drinks, if 
they smoked, how often they did different kinds of activities, if they did sport, where 
and how often they did physical activity, the reasons why they didn’t do sport or 
physical activity, what their job was and how it was organized, and during free time 
what they preferred doing (questions 3-9, 12-18 respectively).  
 
Questions about patient’s lifestyle 
Item CSII MDI Whole Sample 
3 
 







































Have lunch at home 
 (94.4%) 
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Eat carbohydrates more 
times per day (43.8%) 
 
Eat carbohydrates one 
time per day (43.8%) 
 
 
Eat carbohydrates more 
times per day (41.8%) 
 
 
Eat carbohydrates more 
times per day (42.1%) 
 
 
Eat cold cuts a few times 
per week (43.8%) 
 
 
Eat cold cuts a few times 
per week (52.7%) 
 
 
Eat cold cuts a few times 
per week (51.6%) 
 
 












Don’t drink milk (31.3%) 
 
 








Eat dairy products few 
times per week (56.3%) 
 
 
Eat dairy products few 
times per week (63.6%) 
 
 
Eat dairy products few 
times per week (62.7%) 
 
 
























Eat vegetables few times 
per day (62.5%) 
 
 
Eat vegetables few times 
per day (52.7%) 
 
 
Eat vegetables few times 
per day (54.0%) 
 
 
































Eat potatoes few times per 
week (64.3%) 
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Eat snacks less than once 
a week (43.8%) 
 
 
Eat snacks less than once 
a week (48.2%) 
 
 
Eat snacks less than once 
a week (47.6%) 
 
 
Eat desserts less than once 
a week (50%) 
 
 
Eat desserts less than once 
a week (50.9%) 
 
 
Eat desserts less than once 





Drink water over one litre 
per day (68.8%) 
 
 
Drink water over one litre 
per day (71.8%) 
 
 
Drink water over one litre 
per day (71.4%) 
 
 












Drink rarely beer (68.8%) 
 
Drink rarely beer (47.3%) 
 
 
Drink rarely beer (50%) 
 
 
Don’t drink wine (50%)  
 
 
Don’t drink wine (40.9%)  
 
 
Don’t drink wine (42.1%)  
 
 












Drink two/three coffees 
per day (25%) and 
use sweetener (46.2%) 
 
Drink three coffees per 
day (23.8%) and 
use sweetener (58.9%) 
 
Drink three coffees per 
day (24.0%) and 









































Watch DVDs and VDTs 








Watch DVDs and VDTs 
few times per year 
(45.2%) 
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Don’t use PC (53.6%) 
 
 
Don’t use PC (49.2%) 
 
 












Read every day (56.3%) 
 
 
Read every day (41.8%) 
 
 
Read every day (43.7%) 
 
 
Go to the theatre or 



























Do food shopping more 
times a week (50%) 
 
 
Do food shopping more 
times a week (33.9%) 
 
 
Do food shopping more 
times a week (36%) 
 
 



























Don’t do any sports 
(68.8%) 
 









Results  34 
 
 
Giulia Abis, Diabetes and Medical Devices: which Device for which Patient 






Don’t do any physical 
activity (43.8%) 
 
Don’t do any physical 
activity (52.7%) 
 







Don’t do any sport neither 
physical activity (37.5%) 
 
 
Don’t do any sport neither 
physical activity (43.6%) 
 
 
Don’t do any sport neither 






Don’t do much sport or 
physical activity due to 
the health (31.3%) 
 
 
Don’t do much sport or 
physical activity due to 
the job (30%) 
 
 
Don’t do much sport or 
physical activity due to 






Don’t work (37.5%) 
 




Don’t work (52.7%) 
 





Have all week the same 
shifts (31.3%) 
 
Decide how to organize 




Decide how to organize 







During free time prefer to 
take a walk (56.3%) 
 
 
During free time prefer to 
take a walk (30%) 
 
 
During free time prefer to 
take a walk (33.3%) 
 
Table 8. Modal values and corresponding frequencies of items about patient's lifestyle in patients by medical 
devices groups 
In Table 9, as regards clinical parameters, the percentages of outliers patients from 
standard values for blood tests of Laboratory of ASSL Oristano are reported.  
The relationship between categorized BMI (0=normalweight; 
1=over/underweight) and medical device is statistically significant (χ2 =4.0216; p <.05).  
The relationships between gender and the following categorized variables (0=normal; 
1=outlier standard values) creatinine, HDL cholesterol, triglyceride, are statistically 
significant (p<.05). Also, the relationships between the type of diabetes and the 
categorized variables (0=normal; 1=outlier standard values) ACR, triglyceride, BMI, 
cardiac anomalies are highly statistical significant (p<.001).  
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Finally, the relationships between the age of patients and the categorized variables 
(0=normal; 1=outlier standard values) ORD, BMI, cardiac anomalies, are statistical 
significant (p<.005). 
Also, 47.2% take cholesterol medications, 29.4% take anticoagulants drugs, 
43.7% are treated with hypertension drugs and 52% take other drugs.  
The relationship between the type of diabetes and the assumption of anticoagulants, 
hypertension and other drugs are statistically significant (p<.05).  
The relationships between age of patients and the assumption of drugs is resulted highly 
statistical significant (p< .001). 
The relationship between the type of diabetes and the assumption of anticoagulants 
drugs is statistically significant (p<.05). 
 
Clinical variables % of outliers 
Creatinine (mg/ml) 66.9 % 
Creatinine Albumin Ratio, ACR (mol/mmol) 5.7 % 
Glutamic-Pyruvate Transaminase, GPT (UI/L) 27.4 % 
Cholesterol (mg/dl) 29.5 % 
HDL Cholesterol (mg/dl) 18.9 % 
Triglyceride (mg/dl)  10.7 % 
LDL Cholesterol (mg/dl) 50.4 % 
Glycated Hemoglobin, HbA1c (%) 88.1 % 
Body Mass Index, BMI 71.2 % 
Diabetic Retinopathy, ORD 38.1 % 
Cardiac Anomalies 49.2 % 
Table 9. Percentage of patients with outliers values for clinical parameter 
 Furthermore, we analysed the relationships between the items of the PLDI 
questionnaire, clinical variables and age. In Table 10 only the statistical significant 
relationships at significant level 0.05 are shown. 
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Take other drugs 
6 – eat 
carbohydrates 
Cardiac anomalies 
6 – eat 
cured meat 
ACR 
Take cholesterol medications 
Take antihypertensive drugs 
6 – eat meat 
Creatinine 
HbA1c 
6 – drink milk 
HDL 
BMI 
6 – eat 
dairy product 
Triglyceride 
Take cholesterol medications 
Take antihypertensive drugs 
Take other drugs 
ORD 
Cardiac anomalies 
6 – eat vegetables GPT 
6 – eat snacks 
Take cholesterol medications 
BMI 
6 – eat desserts 
Take antihypertensive drugs 
ORD 
BMI 
7 – drink water GPT 
Results  37 
 
 
Giulia Abis, Diabetes and Medical Devices: which Device for which Patient 
Tesi di Dottorato in Scienze Biomediche – Curriculum Sanità Pubblica, Università degli Studi di Sassari 
 
Item of PLDI 
questionnaire 
Clinical Variable 
7 – drink beer 
ACR 
Take cholesterol medications 
Take anticoagulant drugs 
Take antihypertensive drugs 
Take other drugs 
Cardiac anomalies 
BMI 
7 – drink wine 
ACR 
Take cholesterol medications 
Take anticoagulant drugs 
Take antihypertensive drugs 
7 – drink other 
spirits 
Take cholesterol medications 
Take antihypertensive drugs 
BMI 
8 
Take cholesterol medications 
Take antihypertensive drugs 




  Table 10. Significant relationships between items of PLDI questionnaire and clinical variables and age 
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4.2.3 EFA results 
We conducted an Exploratory Factor Analysis (EFA) of the questionnaire 
responses and demographic information (age, MD and type of diabetes) to further 
understand and identify characteristics of people with T1D and T2D in insulin 
treatment. The number of cases used in the EFA analysis was 125 because, by default, 
SPSS does a listwise deletion of incomplete cases. 
The observable variables used for the analysis were 12: Age (years), MD, Type of 
Diabetes, Breakfast, Lunch, Fruits Vegetables, Technology, Qualification, Sport, 
Physical Activity, Work and Work Shifts. We respected the rule of thumb of 10 
observations per variable (Pannocchia & Giannini, 2007). The other variables of the 
questionnaire had been progressively excluded to get the best model that fits the data. 
The mean Age of respondents was 52 ± 13. MD is 0 for MDI technology and 1 for 
CSII technology. Responses in the Likert scale was based on five points ranging from 
low risk to high risk. Variable Sport reported 0 for answer “don’t sport” (Likert scale 
points 4, 5) and 1 for answer “do sport” (Likert scale points 1, 2, 3). For variables Fruits 
Vegetables and Technology we did the average of the questionnaire questions indicated 
for each respondents. Each of the 12 observed variables received equal weight. 
Three major sequential steps were undertaken for EFA.  
Step 1 involved identifying the number of meaningful factors to retain based on 
Kaiser’s Criterion (eigenvalue >1) and the percentage of common variance accounted 
for by a given factor. We used maximum likelihood extraction’s method because we 
have assumed that the measured variables are the best representative of the measurable 
variables of the population that is the results are extendable to population. We involved 
a varimax (orthogonal) rotation on the retained factors because it minimizes the number 
of variables that have high loadings on each factor and works to make small loadings 
even smaller. Furthermore, varimax rotation was applied because a correlation between 
factors had previously been hypothesized, but it hadn’t been supported by oblimin 
rotation.The factors were selected if their eigenvalue was > 1, as is the Kaiser’s 
criterion. 
As showed in Table 11, a four-factor solution was supported by the 62% 
percentage of variance accounted. The first factor accounted for 27% of the variance 
and the second, the third and the fourth factor accounted for an additional 14%, 12%, 
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9% respectively. Subsequent factor independently accounted for progressively lower 
percentages of variance. 
 
Total Variance Explained 
Factor 
Initial Eigenvalues 
Extraction Sums of Squared 
Loadings 

















1 3.265 27.208 27.208 1.257 10.476 10.476 2.100 17.497 17.497 
2 1.662 13.852 41.061 2.270 18.919 29.396 1.777 14.806 32.303 
3 1.416 11.800 52.861 1.390 11.587 40.983 1.024 8.533 40.836 
4 1.085 9.038 61.899 .847 7.057 48.040 .865 7.204 48.040 
5 .859 7.158 69.057 
      
6 .793 6.611 75.668 
      
7 .675 5.627 81.294 
      
8 .619 5.155 86.449 
      
9 .578 4.818 91.267 
      
10 .544 4.530 95.797 
      
11 .349 2.905 98.702 
      
12 .156 1.298 100.000 
      
Extraction Method: Maximum Likelihood  
                      Table 11. Total variance explained by factors in EFA 
  
The common variance assessed, which is always smaller than the total variance, was 
48%. After varimax rotation the percentages of variance accounted was redistributed 
over the four extracted factors (rotation sums of squared loadings, Table 11).  
The proportion of variance of each item that is explained by the factors is reported 
in Table 12. Communalities were calculated of the initial solution and then after 
extraction. They are the reproduced variances from the factors that we extracted. 
Variables with high values are well represented in the common factor space, while 
variables with low values are not well represented. 
Variables with communality <.20 have unique variance and don’t contribute to 
explain variance for factors. So, MD and Lunch don’t contribute to explain variance for 
factors. 
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Age .450 .554 
MD .161 .194 
Type Diabetes .292 .338 
Breakfast .163 .326 
Lunch .144 .181 
Qualification .385 .428 
Physical Activity .142 .952 
Work .723 .796 
Work Shifts .711 .897 
Fruits Vegetables .161 .304 
Technology .432 .521 
Sport .239 .274 
        Table 12. Communalities of observed variables in EFA 
                                      
Step 2 involved evaluation of the goodness of the model. We considered Kaiser-
Meyer-Olkin and Bartlett’s Tests and the goodness of adaptation test. 
 
KMO and Bartlett’s Test 
Kaiser-Meyer-Olkin Measure of Sampling Adequacy .705 
Bartlett’s Test of Sphericity Approx. Chi-square 382.153 
Df 66 
Sig. .000 
                      Table 13. Goodness of fit Indices of the model  
A value of .71 for KMO test suggested a mid-suiting model for the data in EFA. 
Significant χ2 for Bartlett’s test shows not homogeneity of variance. Taken together, 
these tests provide a minimum standard which should be passed before a factor analysis 
should be conducted. 
The Chi Square test (χ2=19.228) revealed that the four factors model is a good 
description of the data (p=.74).  
Step 3 involved interpreting the rotated solution by identifying which observable 
variables load on each retained factor. Table 14 contains the rotated ordered factor 
loadings which represent both how variables are weighted for each factor but also the 
correlation between the variables and the factors. Because these are correlations, 
possible values range from +1 to -1.  
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Rotated Factor Matrix 
 Factor 
1 2 3 4 
Technology .666 
   
Age .661 
   
Qualification .589 
   
Type Diabetes .575 
   
Sport -.455 
   
MD -.408 














   
.552 
Fruits Vegetables 
   
.524 
Lunch 
   
.352 
Extraction Method: Massimum Likelihood 
Rotation Method: Varimax with Kaiser Normalization 
4 factors extracted 
25 iterations requested 
        Table 14. Rotated Factor Matrix of EFA 
                                
Items allocated to a specific factor were based on a loading of ≥ .30 on that factor. This 
makes the output easier to read by removing the clutter of low correlations that are 
probably not meaningful anyway. 
As you can see by the footnote of Table 14 four factors were extracted according to the 
variance explained (see Table 11). Factor 1 consisted of 6 items (Technology, Age, 
Qualification, Type Diabetes, Sport, MD) and was labeled “General Characteristics”. 
Factor 2 consisted of 2 items (Work Shifts, Work) and was labeled “Employment 
Information”. It was considered reliable because the variables are highly correlated with 
each other (r = .833). Factor 3 consisted of 1 item (Physical Activity) so it wasn’t 
considered as a factor. Factor 4 consisted of 3 items (Breakfast, Fruits Vegetables, 
Lunch) and was labeled “Eating Habits”. 
According with orthogonal rotation, such as the varimax, the factors are not permitted to 
be correlated (they are orthogonal to one another). 
The theory about the proportion between observed used variables and extracted factors 
is respected because we used a mean of four observed variables for one factor. 
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4.2.4 CFA results 
Confirmatory Factor Analysis (CFA) was performed to test the model defined by 
the EFA as well as a three-factor model using the maximum likelihood estimation 
method. Thus, we tested two primary hypothesis: 
- H1, the profile is explained by three dimensions (EFA result); 
- H2, the profile is explained by four dimensions (EFA result and clinical 
factor). 
Figure 2 displays the path diagram based on EFA’s results. Observed variables are 
represented with rectangles and unobserved variables are represented with ovals 
(factors) and with circles (unique factors, measurement errors in the variables). 
Factor General Characteristics is connected with six observed variables Technology, 
Age_Cat, Qualification, Type Diabetes, Sport, MD with straight lines pointing from the 
factor. Differently from EFA, we used the observed variable Age_Cat that is a 
categorization of the variable Age. This choice was taken to ensure homogeneous units 
of measure of observed variables. Table 15 shows the corresponding categorization of 
the age used in the CFA analysis. For greater clarity, the results showed on the path 
diagram  (Figure 2)  are essentially the same as the CFA using the variable Age (years). 
 
Age Age_Cat 
≤ 30 years old 1 
31 ≤ years old ≤  50 2 
51 ≤ years old ≤  70 3 
           Table 15. Categorization of observed variable Age considered into CFA model 
In the path diagram, Factor Employment Information is connected with two observed 
variables Work Shifts, Work with straight lines pointing from the factor. Factor Eating 
Habits is connected with three observed variables Breakfast, Fruits Vegetables, Lunch 
with straight lines pointing from the factor.  
Each error is connected with each only observed variable to which is associated with a 
straight line pointing from the unique factor.  
The three factors General Characteristics, Employment Information, Eating Habits are 
connected by two-headed curved arrows. 
Results  43 
 
 
Giulia Abis, Diabetes and Medical Devices: which Device for which Patient 
Tesi di Dottorato in Scienze Biomediche – Curriculum Sanità Pubblica, Università degli Studi di Sassari 
 
The specific model in Figure 2 is identified, so it is possible to come up with the 
unique parameter estimates.  
That is, AMOS 24 introduced some constraints to identify the model because the scales 
of latent variables were unknown and had to be estimated. It set the weights of MD, 
Work, Lunch and the variances of unique factors to one. 
The CFA results support our hypothesis realized on EFA model.  
The model matches the observed data very well; the model adequacy measured with the 




   Figure 2. Path diagram based on EFA results 
Table 16 shows the obtained absolute and incremental fit indexes compared with 
the recommended values.  
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Fit Statistic Recommended Value Obtained Value 
Absolute Fit Indexes 
GFI >.90 .938 
AGFI >.90 .900 
RMR <.05 .047 
RMSEA <.05 .033 
Incremental Fit Indexes 
NFI >.90 .872 
TLI >.90 .976 
CFI >.90 .982 
              Table 16. Absolute fit indexes value obtained in CFA 
These results indicate overall a very appropriate fit of the factors model. 
 
Under Hypothesis 2, in our study we tested the three-factors model above with the 
addition of another factor named Clinical Information regarding observed variables 
about HbA1c (glycated hemoglobin), ACR (creatinine albumin ratio), GPT (glutamic-
pyruvate transaminase) values, cholesterol and other medication intake, heart 
abnormalities, BMI (body mass index) and ORD (diabetic retinopathy).  
This model is unidentified, so it was not possible to come up with unique parameter 
estimates and we finally accepted the model under Hypothesis 1, showed in Figure 2.  
Correlations between factors in the standardized model of path diagram in Figure 2 are 
reported in Table 17. 
 
Factors Estimate 
General Characteristics  Employment Informations -.462 
Employment Informations  Eating Habits -.187 
General Characteristics  Eating Habits -.033 
Table 17. Correlations of factor model with standardized parameters 
 
Standardized parameter estimates are reported in Table 18 and shown in Figure 3. 
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The path diagram with standardized parameter estimates shows existing relationships 
between observed variables and latent variables and between the three factors.  
The weights are all high, specifically those related to factor Employment Information. 
There is also an important correlation between the factors Employment Information and  
General Characteristics, while Eating Habits has not significant correlation values with 
the other factors. 
 
Observed Variable  Factor Estimate 
MD  General Characteristics .387 
Sport  General Characteristics .446 
Type Diabetes  General Characteristics -.548 
Qualification  General Characteristics -.684 
Age_Cat  General Characteristics -.598 
Technology  General Characteristics -.696 
Work  Employment Information .979 
Work Shifts  Employment Information .851 
Lunch  Eating Habits .442 
Fruits Vegetables  Eating Habits .425 
Breakfast  Eating Habits .561 
Table 18. Standardized Regression Weights  
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If we consider only the statistically significant relationships, the number of variables 
that we have to take into account are much less. In Table 19 we reported only the 
standardized regression weights and the correlations between factors significant. 
 
Variable  Factor Estimate P 
Sport  General Characteristics .446 .002 
Fruits Vegetables  Eating Habits .425 .028 
Breakfast  Eating Habits .561 .040 
General Characteristics  Employment Informations -.462 .003 
                       Table 19. Statistically significant regression weights and correlation 
Figure 3. Path diagram with standardized parameters 
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Figure 4 shows the path diagram with colored statistically significant regression weights 
and correlation. 
 
Green colored straight arrows are the statistically significant regression weights and the 
two-headed curved green colored arrow is the correlation between General 
Characteristics and Eating Habits latent variables. The red colored straight arrows are 
the regression weights of observed variables used as constraints to estimate the variance 
of the latent variables: so that we can’t say anything about their statistical significant. 
From what has been highlighted in the colored path diagram, we can say that two blocks 
are defined: General Characteristics and Employment Information together are the first 
block and Eating Habits is the second one.  
     Figure 4. Path diagram of CFA model 
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In the first block there is a statistical significant correlation between the two factors, but 
the Employment Information, despite the high value of factor loadings, doesn’t “cause” 
any observed variables (statistically significant point view). About General 
Characteristics it is interesting that the only statistically significant regression weights 
is that about Sport variable. 
The second block shows how eating habits are important to define the characteristics of 
people with T1D and T2D, independently by medical devices used. 
 
4.2.5 Multiple linear regression results 
Multiple linear model was performed to estimate the effects on the costs related to 
medical devices used. Cost was the dependent variable in the model, while as 
independent variables were considered: 
- the four factors results of EFA (General Characteristics, Employment 
Informations, Physical Activity, and Eating Habits); 
- non-categorized clinical information about glycaeted hemoglobin (HbA1c), 
creatinine albumin ratio (ACR), glutamic-pyruvate transaminase (GPT), 
cardiac anomaly (CA), body mass index (BMI) and diabetic retinopathy 
(ORD); 
- type of diabetes, coded one for T1D and two for T2D; 
- cholesterol and other medication intake, coded zero if patient didn’t intake,  
one if they did. 
All variables were included into the analysis with stepwise method (criteria 
probability of F to enter  ≤ .05 and probability of F to remove ≥ .01). 
 
The analysis was performed on 98 cases, or 73.1% of the observations (see 4.2.1). 
The variable Cost has a mean of 613.4 €   1458.5 €. 
Two models were estimated: Model 1 with only General Characteristics and Model 2 
with General Characteristics and Eating Habits as variables.  
These models explained a significant portion of the variability of the data (see Table 
20). 
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ANOVA 
Model SS df MQ F p 
1 
Regression 57526642.402 1 57526642.402 37.111 .000
b
 
Residual 148811262.744 96 1550117.320   
Total 206337905.146 97    
2 
Regression 65862875.655 2 32931437.827 22.271 .000
c
 
Residual 140475029.491 95 1478684.521   
Total 206337905.146 97    
a. Dependent variable: Cost 
b. Predctors: (constant), General Charateristics  
c. Predictors: (constant), General Charateristics, Eating Habits 
                        Table 20. ANOVA table: fit of regression models 
Table 21 shows the estimates of the coefficients. The i column describes the estimation 
not standardized of linear model parameters; the SE column provides an estimate of the 
relative standard error; the Sign column shows the p-value. 
 
Coefficients 
 Variable i SE Sign 
Model 1 
General Characteristics -910.67 149.49 .000 
Constant 626.16 125.79 .000 
Model 2  
General Characteristics -933.96 146.33 .000 
Eating Habits 408.7 171.87 .020 
Constant 616.43 122.92 .000 
                         Table 21. Coefficients and significant value of multiple linear regression models 
 
We conducted a further linear regression analysis were the dependent variable was 
Cost and the only independent variable was the non-categorized clinical information 
about glycaeted hemoglobin (HbA1c), but in spite of what reported in literature, the 
model was statistically not significant (F=.329; p=.567). 
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4.3 Patient’s Profile 
Considering the path diagram by CFA analysis we defined the profile of patients 
with type 1 and 2 diabetes in insulin treatment that used MDI (group one) and CSII 
(group two) starting by count of each PLDI questionnaire’s item.  
The only thing that we could do was to show the substantial differences between 
patients that use the two different MD, for the three factors and observed variables of 
CFA (see 4.2.4). The main differences between MDI and CSII groups were in the 
frequency of use technology devices and their applications (pc, smartphone, internet, 
videogames, etc.), in the qualification, in the type of diabetes, in the work and its shift. 
Table 22 shows the percentage of response for each item by the two different MD used 
by patients, with highlighted colour for the significant differences among two groups for 
each observed variables related at latent variable. 
We can highlight that: 
- 76% of CSII users make use of technology more than once a week versus 29% 
of MDI users; 
- 69% of CSII group have at least a secondary school degree versus 28% of MDI 
group; 
- patients who use CSII technology are mostly T1D patients (94%) differently 
from patients who use MDI technology that are almost similarly distributed: 
this is in accordance with international guidelines that recommend the use of 
CSII in people with T1D diabetes (ADA, 2014; NICE, 2010); 
- patients which use CSII technology have every week the same work shifts 
(31%) versus MDI users that they decide their work shifts or they don’t work 
(both 26%); 
- patients which use CSII technology are likewise employees or unemployed 
(both cases 38%), while most of MDI users don’t work (52%); 
- equal percentage of responses in the two groups of patients have been counted 
about age, sport and eating habits in general, although in some cases the 
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3% 13% Use technology device every day .065 
25% 63% 
Use technology device more than once a 
week 
.0019 
32% 12% Use technology device once a week .101 
37% 12% 
Use technology device less than once a 
week 
.048 
3% 0% Never .483 
Age_cat 
10% 19% ≤ 30 years old .286 
22% 37% 31 ≤ years old ≤  50 .189 
68% 44% 51 ≤ years old ≤  70 .060 
Qualification 
6% 31% University Degree, Phd .001 
22% 38% High school .162 
53% 19% Secondary School .010 
16% 12% Primary School .679 
3% 0% None .483 
Type 
Diabetes 
49% 94% T1D .001 
51% 6% T2D .001 
Sport 
83% 69% Don't do sport .181 




24% 31% Every week have the same work shifts .545 
5% 6% Every week have different work shifts .866 
19% 19% 
Every day they know when I start, but 
not when I'll finish 
1 
26% 25% I decide my work shifts .932 
26% 19% Don't work .547 
Work 
28% 38% Employees .412 
3% 13% Contributors .065 
17% 6% Self-employees .257 
0% 5% Students .019 
52% 38% Don't work .295 
Eating Habits 
Breakfast 
2% 25% Eat also fruits and drink .001 
67% 44% Drink but don't eat .073 
25% 31% Eat and drink .608 
3% 0% Eat but don't drink .483 
3% 0% No breakfast .483 
Fruits 
Vegetables 
47% 50% Eat them more than once a day .822 
26% 19% Eat them once a day .547 
20% 25% Eat them more than once a week .645 
5% 6% Eat them less than once a week .866 
2% 0% Don't eat them .568 
Lunch 
94% 94% At home 1 
2% 6% At canteen, trattoria, restaurant, hot table .340 
0% 0% At the bar 1 
3% 0% During work .483 
1% 0% Don't have lunch .688 
Table 22. Profiles for MDI and CSII patients considering factor resulted by CFA with p-value in dark bold 
when p<.05 
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This thesis investigates the profiles of patients with T1D and T2D in treatment 
with Multiple Daily Injection (MDI) or Continuous Subcutaneous Insulin Infusion 
(CSII) medical devices. Both MDI and CSII are forms of intensified insulin treatment, 
but CSII mimics a physiological situation better (Jeitler, et al., 2008). Moreover, the 
number of patients with T1D and T2D that use CSII increased by 396% in the period 
2005-2013 (Bruttomesso, et al., 2015). International associations recommend CSII for 
patients who attempt to achieve target haemoglobin levels following high levels of 
HbA1c (8.5% or above) with MDI despite carefully managing their diabetes (NICE, 
2008). This study was conducted with the aim of researching the differences between 
patients who use MDI and CSII, not necessary clinical, to identify the patients eligible 
for the use of CSII. 
Firstly, we developed a questionnaire to study the way of life of patients with 
diabetes in insulin-treatment that we called Patients’ Lifestyle with Diabetes Insulin-
treated (PLDI) questionnaire to investigate patients’ lifestyle. The PLDI questionnaire 
was validated during a pilot study and contains questions about perception of health, 
satisfaction of medical device and patient’s lifestyle.  
Secondly, we conducted an Exploratory Factor Analysis (EFA) of the 
questionnaire responses and demographic information (age, medical device and type of 
diabetes) to further understand and identify the factors that describe the characteristics 
of people with T1D and T2D in insulin treatment. Three factors were lastly extracted: 
“General Characteristics” (with variables Technology, Age, Qualification, Type 
Diabetes, Sport and MD), “Employment Information” (with variables Work Shifts and 
Work) and “Eating Habits” (with variables Breakfast, Fruits Vegetables and Lunch). 
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Thirdly, we tested the EFA model result by using Confirmatory Factor Analysis 
(CFA) and we found two blocks: General Characteristics and Employment Information 
together are the first block and Eating Habits is the second one. In the first block there 
is a statistical significant correlation between the two factors, and the second block 
shows how eating habits are important to define the characteristics of people with T1D 
and T2D, independently by medical devices used. 
Then, we performed a multiple linear regression model to estimate the effects on 
the costs related to medical devices used. Also in this case, two models were estimated: 
Model 1 with only General Characteristics and  Model 2 with General Characteristics 
and Eating Habits as independent variables. 
Finally, we studied the meaningfulness of percentage differences between patients 
that use MDI or CSII related to the three-factor model. That is, we can safely say those 
have CSII for insulin treatment compared to those have MDI: 
- are used to using technology much more often; 
- have a higher education; 
- are affected by T1D; 
- can be students; 
- have a more balanced breakfast. 
The added value of this work is that we studied the lifestyle of patients with diabetes in 
insulin treatment related to the medical devices that they use. We found interesting 
differences between the two groups that can be useful for reducing healthcare costs 
related to diabetic pathology.   
These results, which can represent the straightness of our study,  provide supporting 
evidence that there are many, not only clinical, characteristics of patients with diabetes 
useful to the appropriate choice of medical device for insulin treatment. These 
characteristics are: familiarity with technology, qualification, type of diabetes, job and 
breakfast habits. It is obvious that the percentage of HbA1c has not resulted the core 
solution for the choice of medical device, as literature reports.  
On the other hand, this study is not devoid of limitations. The main is based on the 
sample and its composition: it is not too consistent and is not representative of the 
general diabetic population for the selection bias of the choice of diabetic center, which 
limits the generalizability of results. Therefore, the next development is to carry on a 
multicenters study and make the results more generalizable in order that they can be 
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used by policy makers in healthcare for a better management of resources and the best 
appropriateness of patients’ eligibility at the use of CSII technology.  
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CONSENSO INFORMATO 
Dichiarazione da parte dell’Assistito di età ≥ 18 anni di ricevuta informazione e  
consenso all’utilizzo dei dati 
 
PROGETTO 
“DIABETE E DISPOSITIVI MEDICI: QUALE DISPOSITIVO PER QUALE PAZIENTE?” 
Il/la sottoscritto/a ______________________________________________ nato/a a 
___________________________  il ___________________________  
 
Dichiara di: 
 essere stato adeguatamente informato dal proprio medico Diabetologo del Servizio di 
Diabetologia Dott. ______________________________________ su obiettivi e 
modalità del progetto di ricerca “Diabete e Dispositivi Medici: quale dispositivo per 
quale paziente?”; 
 di aver preso atto che il proprio medico Diabetologo ha aderito al progetto di ricerca 
“Diabete e Dispositivi Medici: quale dispositivo per quale paziente?” per la tesi di 
Dottorato in Sanità Pubblica (Scuola di Dottorato in Scienze Biomediche 
dell’Università degli Studi di Sassari);  
 di essere stato informato dal mio medico Diabetologo di quali dati clinici presenti 
nella propria cartella clinica saranno utilizzati nell’ambito di tale progetto; 
 di essere stato informato dal mio medico Diabetologo di dover essere sottoposto ad un 
questionario sotto forma di intervista nell’ambito di tale progetto; 
 di essere consapevole che tale progetto non interferisce in alcun modo sul mio 
processo di cura; 
 di essere a conoscenza che i dati forniti mediante la cartella clinica e mediante il 
questionario saranno utilizzati ai soli fini di ricerca e di valutazione epidemiologica, 
che tali valutazioni avverranno garantendo il rispetto dell’anonimato, con procedure a 
tutela della privacy e con la diffusione dei risultati esclusivamente in forma aggregata 
senza poter risalire in qualsiasi modo a me; 
Autorizzo: 
 il mio medico Diabetologo all’utilizzo dei dati personali, sopra riportati, contenuti 
nella cartella clinica per i fini sopra riportati all’interno del progetto di ricerca 
“Diabete e Dispositivi Medici: quale dispositivo per quale paziente?”; 
 alla diffusione e pubblicazione dei risultati dello studio, completi o parziali, in forma 
aggregata; 
  
  Luogo e Data        Firma 
          (estesa e leggibile) 
                      
                        _______________________            _________________________ 
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Data rilevazione:  
Codice paziente:  
 
DISPOSITIVO MEDICO TECNOLOGIA MDI 
ESAMI CLINICI DEL SANGUE (ULTIMA RILEVAZIONE) 
Data Esame Risultato 
 Creatinina (mg/ml)  
 ACR (mg/mmol)  
 GPT (UI/L)  
 Colesterolo (mg/dl)  
 Colesterolo HDL (mg/dl)  
 Trigliceridi (mg/dl)  
 Colesterolo LDL (calc) (mg/dl)  
 Emoglobina glicata HbA1c (%)  
   
ALTRI ESAMI 
Data Esame Risultato 
 Peso (kg)  




 Pressione Sistolica (mmHg)  
 Pressione Diastolica (mmHg)  
   
ESAMI OCULISTICI (ULTIMA RILEVAZIONE) 
Data Esame Risultato 
 Retinopatia diabetica □      Si □      No 
    
ESAME CARDIOLOGICO ECG (ULTIMA RILEVAZIONE) 
Data Esame Risultato 





FARMACI ASSUNTI (ULTIMA RILEVAZIONE) 
Data Esame Risultato 
 Ipocolesterolemizzanti □      Si, ________________ □      No 
 Antiaggreganti □      Si, ________________ □      No 
 Antipertensivi □      Si, ________________ □      No 
    
TERAPIA INSULINICA (ULTIMA RILEVAZIONE) 
Data Terapia Quantità 
 Basal Bolus  
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DISPOSITIVO MEDICO TECNOLOGIA CSII 
ESAMI CLINICI DEL SANGUE 
Ultima rilevazione MDI 
Data Esame Risultato 
 Creatinina (mg/ml)  
 ACR (mg/mmol)  
 GPT (UI/L)  
 Colesterolo (mg/dl)  
 Colesterolo HDL (mg/dl)  
 Trigliceridi (mg/dl)  
 Colesterolo LDL (calc) (mg/dl)  
 Emoglobina glicata HbA1c (%)  
Ultima rilevazione CSII 
Data Esame Risultato 
 Creatinina (mg/ml)  
 ACR (mg/mmol)  
 GPT (UI/L)  
 Colesterolo (mg/dl)  
 Colesterolo HDL (mg/dl)  
 Trigliceridi (mg/dl)  
 Colesterolo LDL (calc) (mg/dl)  
 Emoglobina glicata HbA1c (%)  
 
ALTRI ESAMI 
Ultima rilevazione MDI 
Data Esame Risultato 
 Peso (kg)  




 Pressione Sistolica (mmHg)  
 Pressione Diastolica (mmHg)  
Ultima rilevazione CSII 
Data Esame Risultato 
 Peso (kg)  




 Pressione Sistolica (mmHg)  
 Pressione Diastolica (mmHg)  
 
ESAME OCULISTICO 
Ultima rilevazione MDI 
Data Esame Risultato 
 Retinopatia diabetic □      Si □      No 
Ultima rilevazione CSII 
Data Esame Risultato 
 Retinopatia diabetic □      Si □      No 
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ESAME CARDIOLOGICO ECG 
Ultima rilevazione MDI 
Data Esame Risultato 
 Anomalie Cardiache □      Si □      No 
 Se si, quali: _______________________________________________ 
Ultima rilevazione CSII 
Data Esame Risultato 
 Anomalie Cardiache □      Si □      No 
 Se si, quali: _______________________________________________ 
 
FARMACI ASSUNTI 
Ultima rilevazione MDI 
Data Esame Risultato 
 Ipocolesterolemizzanti □      Si □      No 
 Se si, quali: _____________________________________________ 
 Antiaggreganti □      Si □      No 
 Se si, quali: ______________________________________________ 
 Antipertensivi □      Si □      No 
 Se si, quali: ______________________________________________ 
Ultima rilevazione CSII 
Data Esame Risultato 
 Ipocolesterolemizzanti □      Si □      No 
 Se si, quali: _______________________________________________ 
 Antiaggreganti □      Si □      No 
 Se si, quali: _______________________________________________ 
 Antipertensivi □      Si □      No 
 Se si, quali: _______________________________________________ 
 
TERAPIA INSULINICA 
Ultima rilevazione MDI 
Data  Terapia Quantità insulina 
 Basal Bolus  
Ultima rilevazione CSII 
Data  Terapia Quantità insulina 
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